Dear Colleagues
In spite of major advances in emergency cardiac care, significant numbers of patients suffer cardiac arrest and circulatory failure with a high subsequent mortality in spite of timely revascularisation when appropriate. Resuscitation and the management of circulatory shock therefore represent a key unmet need.
The objective of the course is to bring together an expert faculty and to focus on clinical networks and pathways of care for the management of cardiogenic shock
With best regards. Yours sincerely
Miles Dalby
Course Director
Thomas F. Lüscher
Course Director
Shouvik Haldar
Course Director
In collaboration with
In partnership with
Under the Auspices of
Programme
Venue: Royal Society of Medicine, London | Tuesday, October 12th, 2021
| 08:30-08:45 | Registration and coffee | |
| 8:45-09:00 | Introduction | Miles Dalby |
| 09:00-10:30 |
Session 1: What is cardiogenic shock and how prevalent is it? Chairs: Diana Gorog, Richard Grocott-Mason, Thomas F. Lüscher |
|
| 09:00-09:30 |
Definition and epidemiology of cardiogenic shock From SCAI to the new 2021 ESC HF Guidelines |
Alexandre Mebazaa |
| 09:30-10:00 | Understanding the pathogenesis of cardiogenic shock | Divaka Perera |
| 10:00-10:30 | Discussion | |
| 10:30-11:00 | COFFEE BREAK | |
| 11:00-12:30 |
Session 2: Does mechanical support improve outcomes? Chairs: Seth Bilazarian, Nilesh Pareek, Vas Panoulas |
|
| 11:00-11:20 | Does ARREST change the landscape for MCS in cardiac arrest? | Demetris Yannopoulos |
| 11:20-11:40 |
Current trials with Impella: how much benefit in which patient? The 2018 ECS/EACTS Myocardial Revascularisation Guidelines in the context of recent data |
Christian Hassager |
| 11:40-12:00 | Update on trials of ECMO: from ARREST to EURO-SHOCK | Marcus Flather |
| 12:00-12:30 | Discussion | |
| 12:30-13:30 | LUNCH BREAK and INTERACTIVE INDUSTRY EXHIBITION | |
| 13:30-15:00 |
Session 3: Practical session: when, when not and how to deploy MCS Chairs: Jonathan Hill, Richard Trimlett, Ulrich Stock |
|
| 13:30-13:50 |
Cardiovascular disease during the Covid-19 pandemic The UK experience and the ESC Guidance for the Diagnosis and Management of CV Disease during the Covid-19 Pandemic |
Vas Panoulas |
| 13:50-14:10 |
Unloading the heart in acute myocarditis The Berlin experience and the ESC 2021 HF Guidelines |
Carsten Tschöpe |
| 14:10-14:30 |
How to incorporate ECMO in a shock programme The NICE 2014 and ESC 2021 HF Guidelines |
Alex Rosenberg |
| 14:30-15:00 | Discussion | |
| 15:00-15:30 | COFFEE BREAK | |
| 15:30-17:00 |
Session 4: Networks and delivering a joined-up service Chairs: Nick Curzen, John Greenwood, Shouvik Haldar |
|
| 15:30-16:00 | A model for regional cardiogenic shock networks | Susanna Price |
| 16:00-16:30 | Reaching consensus on pathways of care | Alistair Proudfoot |
| 16:30-17:00 | Discussion | |
| 17:00 | SUMMARY and CLOSING REMARKS | Miles Dalby |
Contributors
Teaching Faculty
Chairpersons
Seth Bilazarian, MD
Vice President Abiomed
Danvers, US
Nick Curzen
Southampton University Hospital NHS Trust
Southampton, UK
John Greenwood
Univeristy of Leeds
Leeds, UK
Diana Gorog
University of Herfordshire & Imperial College
Herfordshire & London, UK
Richard Grocott-Mason
Royal Brompton & Harefield Hospitals
at Guy's and St Thomas' NHS Foundation Trust
London, UK
Shouvik Haldar
Royal Brompton & Harefield Hospitals
Imperial College
London, UK
Jonathan Hill
Royal Brompton & Harefield Hospitals
Imperial College
London, UK
Thomas F. Lüscher
Royal Brompton & Harefield Hospitals
Imperial College and King's College
London, UK
Vas Panoulas
Royal Brompton & Harefield Hospitals
Imperial College
London, UK
Nilesh Pareek
Kings College Hospital
London, UK
Ulrich Stock
Royal Brompton & Harefield Hospitals
London, UK
Richard Trimlett
Royal Brompton & Harefield Hospitals
London, UK
Speakers
Miles Dalby
Royal Brompton & Harefield Hospitals
Imperial College
London, UK
Marcus Flather
University of East Anglia
Norfolk, UK
Christan Hassager
Rigshospitalet
Copenhagen, DEN
Alexandre Mebazaa
Hopital Lariboisière
Paris, FR
Divaka Perera
King's College
London, UK
Susanna Price
Royal Brompton & Harefield Hospitals
Imperial College
London, UK
Alastair Proudfoot
Barts Healthcare NHS Foundation Trust
London, UK
Alex Rosenberg
Royal Brompton & Harefield Hospitals
London, UK
Carsten Tschöpe
Charité - Universitätsmedizin Berlin
Berlin, DE
Demetris Yannopoulos
University of Minnesota
Minneapolis, US
General Information
Registration
Registrations can be made exclusively online on our website
| Registration fees | Regular registration | Virtual |
|---|---|---|
| Non ESC-Members | GBP 80 | GBP 60 |
| ESC-Members (please provide ESC-ID number) | GBP 60 | GBP 40 |
| Paramedics, Residents & Students (age<35) | GBP 25 | GBP 20 |
Modification & Cancellation
All modifications or cancellations must be notified in writing (by mail, fax or e-mail) to Zurich Heart House. For each modification requested by the participant, GBP 15 will be charged for administrative costs. In case of cancellation up to 12th September 2021, deposits will be refunded less 35% for administrative costs. After this date, no refund will be possible.
Organisation
Zurich Heart House, Foundation for Cardiovascular Research
Dr. Ruth Amstein
Christine Lohmann
Hottingerstrasse 14, CH-8032 Zurich, Switzerland
Phone +41 (0) 44 250 40 95, Fax +41 (0) 44 250 40 90
Venue
The Royal Society of Medicine
1 Wimpole St, Marylebone, London W1G 0AE, United Kingdom